{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:47:33Z","timestamp":1761655653471,"version":"build-2065373602"},"reference-count":27,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Pediatric Surgery and Oncology"},{"name":"Department of Biostatistics and Translational Medicine, Medical University of Lodz"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Background: Lymphatic malformations (LM) are rare congenital vascular anomalies caused by abnormal development and growth of lymphatic vessels. These malformations can lead to a wide range of symptoms, from mild swelling to more severe complications. Treatment options remain limited, especially for complex cases. Recent research has suggested that PIK3CA mutations play a key role in the pathogenesis of LM, potentially offering new possibilities for targeted treatment strategies. Methods: In this study, a cohort of 36 patients diagnosed with LM, Klippel-Trenaunay syndrome (KTS), and Proteus syndrome was analyzed. PIK3CA mutations were assessed in tissue samples obtained from the LM during clinically indicated procedures using digital droplet polymerase chain reaction (ddPCR), targeting five hotspots. Results: PIK3CA mutations were found in 18 patients (50%). The most frequent mutation was p.E542K (c.1624G&gt;A), found in 19.44% of patients, followed by p.H1047R (c.3149A&gt;G), p.E545K (c.1633G&gt;A), and p.H1047L (c.3140A&gt;T) each occurring in 11.11% of the cases. Mutations were more common in isolated LMs, with 63.16% of patients exhibiting PIK3CA mutations. Conclusions: PIK3CA mutations are common in LM, supporting the potential for targeted therapies like PI3K inhibitors in treating complex cases. This research highlights the importance of genetic analysis in the management of LM and offers a new therapeutic approach.<\/jats:p>","DOI":"10.3390\/children12111460","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T11:47:19Z","timestamp":1761652039000},"page":"1460","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of the Occurrence of PIK3CA Gene Mutation in Children with Lymphatic Malformation\u2014Single Center Study"],"prefix":"10.3390","volume":"12","author":[{"given":"Justyna","family":"Kukulska","sequence":"first","affiliation":[{"name":"Department of Pediatric Surgery and Oncology, Medical University of Lodz, 90-419 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Sa\u0142aci\u0144ska-\u0141o\u015b","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery and Oncology, Medical University of Lodz, 90-419 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2321-2976","authenticated-orcid":false,"given":"Ewelina","family":"Perdas","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Translational Medicine, Medical University of Lodz, 90-419 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4581-8853","authenticated-orcid":false,"given":"Przemys\u0142aw","family":"Przewratil","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery and Oncology, Medical University of Lodz, 90-419 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/MOH.0000000000000496","article-title":"PIK3CA mutations in vascular malformations","volume":"26","author":"Castillo","year":"2019","journal-title":"Curr. Opin. Hematol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.sempedsurg.2014.07.002","article-title":"Lymphatic malformations: Diagnosis and management","volume":"23","author":"Elluru","year":"2014","journal-title":"Semin. Pediatr. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"104637","DOI":"10.1016\/j.ejmg.2022.104637","article-title":"The VASCERN-VASCA working group diagnostic and management pathways for lymphatic malformations","volume":"65","author":"Ghaffarpour","year":"2022","journal-title":"Eur. J. Med. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/lio2.241","article-title":"Clinical application of molecular genetics in lymphatic malformations","volume":"4","author":"Padia","year":"2019","journal-title":"Laryngoscope Investig. Otolaryngol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/CIRCRESAHA.121.318142","article-title":"Lymphatic Malformations: Genetics, Mechanisms and Therapeutic Strategies","volume":"129","author":"Boon","year":"2021","journal-title":"Circ. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1089\/lrb.2017.0062","article-title":"Treatment of Lymphatic Malformations with the mTOR Inhibitor Sirolimus: A Systematic Review","volume":"16","author":"Wiegand","year":"2018","journal-title":"Lymphat. Res. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/ajmg.a.38105","article-title":"Somatic PIK3CA mutations in seven patients with PIK3CA-related overgrowth spectrum","volume":"173","author":"Yeung","year":"2017","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1172\/JCI71614","article-title":"Genetics of lymphatic anomalies","volume":"124","author":"Brouillard","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_9","first-page":"e72","article-title":"Sirolimus is highly effective for lymph leakage in microcystic lymphatic malformations with skin involvement","volume":"56","author":"Geiger","year":"2017","journal-title":"Int. J. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1038\/s41467-020-16496-y","article-title":"Blockade of VEGF-C signaling inhibits lymphatic malformations driven by oncogenic PIK3CA mutation","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Blesinger, H., Kaulfu\u00df, S., Aung, T., Schwoch, S., Prantl, L., R\u00f6\u00dfler, J., Wilting, J., and Becker, J. (2018). PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0200343"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e172844","DOI":"10.1172\/JCI172844","article-title":"Lymphatic malformations: Mechanistic insights and evolving therapeutic frontiers","volume":"134","author":"Petkova","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/CIRCRESAHA.121.318145","article-title":"Genetic Basis and Therapies for Vascular Anomalies","volume":"129","author":"Queisser","year":"2021","journal-title":"Circ. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13023-023-02893-1","article-title":"Targeted next-generation sequencing for detection of PIK3CA mutations in archival tissues from patients with Klippel\u2013Trenaunay syndrome in an Asian population: List the full names and institutional addresses for all authors","volume":"18","author":"Sasaki","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s13023-021-01929-8","article-title":"A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations","volume":"16","author":"Canaud","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Bredin, H.K., Krakstad, C., and Hoivik, E.A. (2023). PIK3CA mutations and their impact on survival outcomes of patients with endometrial cancer: A systematic review and meta-analysis. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0283203"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13058-020-01284-9","article-title":"Frequency and spectrum of PIK3CA somatic mutations in breast cancer","volume":"22","author":"Chic","year":"2020","journal-title":"Breast Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41698-025-00975-w","article-title":"Comprehensive analysis of PIK3CA mutations in advanced colorectal cancer using circulating tumor DNA profiling","volume":"9","author":"Milsap","year":"2025","journal-title":"NPJ Precis. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13023-021-01898-y","article-title":"Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations","volume":"16","author":"Brouillard","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.gim.2022.07.026","article-title":"Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowth","volume":"24","author":"Wenger","year":"2022","journal-title":"Genet. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jpag.2019.07.003","article-title":"Alpelisib Treatment for Genital Vascular Malformation in a Patient with Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, and Spinal\/Skeletal Anomalies and\/or Scoliosis (CLOVES) Syndrome","volume":"32","author":"Lizarraga","year":"2019","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ajmg.c.30063","article-title":"Proteus syndrome: An update","volume":"137C","author":"Cohen","year":"2005","journal-title":"Am. J. Med. Genet.\u2014Semin. Med. Genet."},{"key":"ref_23","unstructured":"(2020). For purification of genomic DNA from formalin-fixed, paraffin-embedded tissues. QIAamp\u00ae DNA FFPE Tissue Handbook, QIAGEN. Sample & Assay Technologies."},{"key":"ref_24","unstructured":"Bio-Rad Laboratories (2015). Droplet Digital\u2122 PCR. Rare Mutation Detection Best Practices Guidelines, Bio-Rad Laboratories. Available online: https:\/\/www.bio-rad.com\/webroot\/web\/pdf\/lsr\/literature\/Bulletin_6628.pdf."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kobialka, P., Sabata, H., Vilalta, O., Angulo-Urarte, A., Muix\u00ed, L., Zanoncello, J., Mu\u00f1oz-Aznar, O., Olaciregui, N.G., Lavarino, C., and Celis, V. (2021). Low Dose AKT Inhibitor Miransertib Cures PI3K-Related Vascular Malformations in Preclinical Models of Human Disease. bioRxiv.","DOI":"10.1101\/2021.07.16.452617"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40291-017-0278-8","article-title":"Current and Emerging Applications of Droplet Digital PCR in Oncology","volume":"21","year":"2017","journal-title":"Mol. Diagn. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jpeds.2014.12.069","article-title":"Lymphatic and other vascular malformative\/overgrowth disorders are caused by somatic mutations in PIK3CA","volume":"166","author":"Luks","year":"2015","journal-title":"J. Pediatr."}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/12\/11\/1460\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:43:25Z","timestamp":1761655405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/12\/11\/1460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["children12111460"],"URL":"https:\/\/doi.org\/10.3390\/children12111460","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]}}}